Detecção da microdeleção 7q11.23 por MLPA® e estudo clínico dos pacientes com síndrome de Williams-Beuren / Detection of the microdeletion 7q11.23 by MLPA® and clinical study of patients with Williams-Beuren syndrome
AUTOR(ES)
Rachel Sayuri Honjo
FONTE
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia
DATA DE PUBLICAÇÃO
30/05/2012
RESUMO
INTRODUCTION: Williams-Beuren syndrome (WBS) is a genetic disorder caused by a microdeletion in 7q11.23 region. It is characterized by typical facial dysmorphisms, mental retardation, hipersociable behavior, congenital heart disease, mainly supravalvular aortic stenosis (SVAS), and other variable congenital malformations. METHODS: 65 patients (40 males, 25 females), aged 2-59 years old (median = 14 years old), with clinical characteristics suggesting WBS, were evaluated. All patients had normal parents. Multiplex Ligation-dependent Probe Amplification® (MLPA®) was performed with a kit with probes in WBS region (MRC Holland). The probes were hybridized to the DNA and the ligated fragments were amplified by PCR and analyzed with specific software. RESULTS: The deletion for all tested probes in the 7q11.23 region was detected by MLPA® in 55/65 patients. One case of atypical deletion, smaller than 1.5 Mb, was observed in one patient with partial clinical picture of the syndrome. The nine patients without the deletion did not have a definitive clinical diagnosis of WBS. Two patients had positive MLPA® results even though they had negative FISH for WBS. The clinical characteristics of the patients with the typical deletion were: typical facies (98.2%), neuropsicomotor delay (98.2%), hypersociable behavior (94.5%), hyperacusis (94.5%) and congenital heart disease (81.8%). Among the patients with cardiac abnormalities, 42.2% had SVAS (isolated or not), 26.7% had pulmonary valve stenosis and 31.1% had other cardiac anomalies (isolated or grouped). Other findings in patients with deletion comprised: genitourinary abnormalities (85.4%), scoliosis (56.4%), short stature (43.6%), inguinal and/or umbilical hernias (36.4%), arterial hypertension (36.4%, with 20% of these presenting renal arteries stenosis), strabismus (34.5%), microcephaly (30.9%), radioulnar synostosis (10.9%), hypothyroidism (14.5%), and subclinical hypothyroidism (7.3%). Hypercalcaemia was detected in only one patient. Two other patients had nephrocalcinosis and one patient had hypercalciuria, with normal serum calcium levels. Three adolescents died due to cardiovascular problems, including one case that died after a cardiac transplantation. CONCLUSIONS: MLPA® was effective to detect the microdeletion in 7q11.23 region confirming the diagnosis of WBS in 84.6% of the patients. It was also possible to detect a small atypical deletion in one patient with partial phenotype and confirm the diagnosis in two patients with typical clinical characteristics of WBS and negative FISH results. Thus, MLPA® is a promising method in the diagnostic investigation of WBS. WBS is a multisystemic disorder and therefore requires multidisciplinary care and specific follow-up in order to prevent complications
ASSUNTO(S)
aortic stenosis supravalvular biologia molecular elastin elastina estenose aórtica supravalvular molecular biology multiplex ligation-dependent probe amplification® multiplex ligation-dependent probe amplification® síndrome de williams williams syndrome
Documentos Relacionados
- Estudo de marcadores polimórficos da região 7q11.23 para o diagnóstico da síndrome de Williams-Beuren
- Detection of deletions at 7q11.23 in Williams-Beuren syndrome by polymorphic markers
- Evolutionary mechanisms shaping the genomic structure of the Williams-Beuren syndrome chromosomal region at human 7q11.23
- Arterial Hypertension in a Child with Williams-Beuren Syndrome (7q11.23 Chromosomal Deletion)
- GTF2IRD2 is located in the Williams–Beuren syndrome critical region 7q11.23 and encodes a protein with two TFII-I-like helix–loop–helix repeats